Eprenetapopt (APR-246) and Azacitidine in TP53 -Mutant Myelodysplastic Syndromes
Sallman, David A, DeZern, Amy E, Garcia-Manero, Guillermo, Steensma, David P, Roboz, Gail J, Sekeres, Mikkael A, Cluzeau, Thomas, Sweet, Kendra L, McLemore, Amy, McGraw, Kathy L, Puskas, John, Zhang, Ling, Yao, Jiqiang, Mo, Qianxing, Nardelli, Lisa, Al Ali, Najla H, Padron, Eric, Korbel, Greg, Attar, Eyal C, Kantarjian, Hagop M, Lancet, Jeffrey E, Fenaux, Pierre, List, Alan F, Komrokji, Rami S
Published in Journal of clinical oncology (10.05.2021)
Published in Journal of clinical oncology (10.05.2021)
Get full text
Journal Article
Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm
Pemmaraju, Naveen, Lane, Andrew A, Sweet, Kendra L, Stein, Anthony S, Vasu, Sumithira, Blum, William, Rizzieri, David A, Wang, Eunice S, Duvic, Madeleine, Sloan, J. Mark, Spence, Sharon, Shemesh, Shay, Brooks, Christopher L, Balser, John, Bergstein, Ivan, Lancet, Jeffrey E, Kantarjian, Hagop M, Konopleva, Marina
Published in The New England journal of medicine (25.04.2019)
Published in The New England journal of medicine (25.04.2019)
Get full text
Journal Article
Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm
Pemmaraju, Naveen, Sweet, Kendra L, Stein, Anthony S, Wang, Eunice S, Rizzieri, David A, Vasu, Sumithira, Rosenblat, Todd L, Brooks, Christopher L, Habboubi, Nassir, Mughal, Tariq I, Kantarjian, Hagop, Konopleva, Marina, Lane, Andrew A
Published in Journal of clinical oncology (10.09.2022)
Published in Journal of clinical oncology (10.09.2022)
Get full text
Journal Article
Prognostic significance of serial molecular annotation in myelodysplastic syndromes (MDS) and secondary acute myeloid leukemia (sAML)
Yun, Seongseok, Geyer, Susan M, Komrokji, Rami S, Al Ali, Najla H, Song, Jinming, Hussaini, Mohammad, Sweet, Kendra L, Lancet, Jeffrey E, List, Alan F, Padron, Eric, Sallman, David A
Published in Leukemia (01.04.2021)
Published in Leukemia (01.04.2021)
Get full text
Journal Article
Comparisons of commonly used front-line regimens on survival outcomes in patients aged 70 years and older with acute myeloid leukemia
Talati, Chetasi, Dhulipala, Varun C, Extermann, Mar Tine, Ali, Najla Al, Kim, Jongphil, Komrokji, Rami, Sweet, Kendra, Kuykendall, Andrew, Sehovic, Marina, Reljic, Tea, Djulbegovic, Benjamin, Lancet, Jeffrey E
Published in Haematologica (Roma) (01.02.2020)
Published in Haematologica (Roma) (01.02.2020)
Get full text
Journal Article
Molecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutations
Ball, Somedeb, Knepper, Todd C., Deutsch, Yehuda E., Samra, Wassim, Watts, Justin M., Bradley, Terrence J., Chan, Onyee, Hussaini, Mohammad Omar, Zhang, Ling, Sweet, Kendra L., Kuykendall, Andrew T., Talati, Chetasi, Padron, Eric, Komrokji, Rami S., Lancet, Jeffrey E., Sallman, David A.
Published in Cancer (01.11.2022)
Published in Cancer (01.11.2022)
Get full text
Journal Article
Disease‐related thrombocytopenia in myelofibrosis is defined by distinct genetic etiologies and is associated with unique prognostic correlates
Kuykendall, Andrew T., Mo, Qianxing, Sallman, David A., Ali, Najla Al, Chan, Onyee, Yun, Seongseok, Sweet, Kendra L., Padron, Eric, Lancet, Jeffrey E., Komrokji, Rami S.
Published in Cancer (01.10.2022)
Published in Cancer (01.10.2022)
Get full text
Journal Article
Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody–drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 study
Daver, Naval G, Montesinos, Pau, DeAngelo, Daniel J, Wang, Eunice S, Papadantonakis, Nikolaos, Todisco, Elisabetta, Sweet, Kendra L, Pemmaraju, Naveen, Lane, Andrew A, Torres-Miñana, Laura, Thompson, James E, Konopleva, Marina Y, Sloss, Callum M, Watkins, Krystal, Bedse, Gaurav, Du, Yining, Malcolm, Kara E, Zweidler-McKay, Patrick A, Kantarjian, Hagop M
Published in The lancet oncology (01.03.2024)
Published in The lancet oncology (01.03.2024)
Get full text
Journal Article
IDH mutations are enriched in myelodysplastic syndrome patients with severe neutropenia and can be a potential for targeted therapy
Komrokji, Rami, Al Ali, Najla, Chan, Onyee, Sweet, Kendra, Kuykendall, Andrew, Lancet, Jeffrey, Padron, Eric, Sallman, David A
Published in Haematologica (Roma) (01.04.2023)
Published in Haematologica (Roma) (01.04.2023)
Get full text
Journal Article
Patterns of lower risk myelodysplastic syndrome progression: factors predicting progression to high-risk myelodysplastic syndrome and acute myeloid leukemia
Jain, Akriti G, Ball, Somedeb, Aguirre, Luis, Al Ali, Najla, Kaldas, David, Tinsley-Vance, Sara, Kuykendall, Andrew, Chan, Onyee, Sweet, Kendra, Lancet, Jeffrey E, Padron, Eric, Sallman, David A, Komrokji, Rami
Published in Haematologica (Roma) (01.02.2024)
Published in Haematologica (Roma) (01.02.2024)
Get full text
Journal Article
Outcomes by best response with hypomethylating agent plus venetoclax in adults with previously untreated acute myeloid leukemia
Jain, Akriti G., Volpe, Virginia O., Wang, Chen, Ball, Somedeb, Tobon, Katherine, Chan, Onyee, Padron, Eric, Kuykendall, Andrew, Lancet, Jeffrey E., Komrokji, Rami, Sallman, David A., Sweet, Kendra L.
Published in Annals of hematology (07.09.2024)
Published in Annals of hematology (07.09.2024)
Get full text
Journal Article
Project Confirm: Accelerated Drug Approvals for CML-Response
Sweet, Kendra L, Cortes, Jorge E, Apperley, Jane F, Mann, Mel, Mauro, Michael J, Oehler, Vivian G, Ruiz, Cristina, Schiffer, Charles A, Ehrlich, Lori A, Pamuk, Gulsum E, Wynne, Joseph, Mehta, Gautam U, Okusanya, Olanrewaju O, de Claro, R Angelo, Theoret, Marc R, Smith, B Douglas, Norsworthy, Kelly J
Published in Clinical cancer research (05.01.2024)
Published in Clinical cancer research (05.01.2024)
Get full text
Journal Article
NCCN and ELN: What do the Guidelines Tell Us?
Sweet, Kendra, Dr, Pinilla-Ibarz, Javier
Published in Best practice & research. Clinical haematology (01.09.2016)
Published in Best practice & research. Clinical haematology (01.09.2016)
Get full text
Journal Article
Project Confirm: Accelerated Drug Approvals for Chronic Myeloid Leukemia
Sweet, Kendra L, Cortes, Jorge E, Apperley, Jane F, Mann, Mel, Mauro, Michael J, Oehler, Vivian G, Ruiz, Cristina, Schiffer, Charles A, Ehrlich, Lori A, Pamuk, Gulsum E, Wynne, Joseph, Mehta, Gautam U, de Claro, R Angelo, Theoret, Marc R, Smith, B Douglas, Norsworthy, Kelly J
Published in Clinical cancer research (13.06.2023)
Published in Clinical cancer research (13.06.2023)
Get full text
Journal Article
Hypomethylating agent and venetoclax in patients with chronic myelomonocytic leukemia: Is the combination indeed better?
Ball, Somedeb, Jain, Akriti G., Aguirre, Luis E., Al Ali, Najla, Zhang, Yumeng, Chan, Onyee, Kuykendall, Andrew T., Sweet, Kendra L., Lancet, Jeffrey E., Swoboda, David M., Padron, Eric, Komrokji, Rami S., Sallman, David A.
Published in American journal of hematology (01.05.2022)
Published in American journal of hematology (01.05.2022)
Get full text
Journal Article
Baseline and serial molecular profiling predicts outcomes with hypomethylating agents in myelodysplastic syndromes
Hunter, Anthony M., Komrokji, Rami S., Yun, Seongseok, Al Ali, Najla, Chan, Onyee, Song, Jinming, Hussaini, Mohammad, Talati, Chetasi, Sweet, Kendra L., Lancet, Jeffrey E., Padron, Eric, List, Alan F., Sallman, David A.
Published in Blood advances (23.02.2021)
Published in Blood advances (23.02.2021)
Get full text
Journal Article
Marrow ring sideroblasts are highly predictive for TP53 mutation in MDS with excess blasts
Swoboda, David M, Kanagal-Shamanna, Rashmi, Brunner, Andrew M, Cluzeau, Thomas, Chan, Onyee, Al Ali, Najla, Montalban-Bravo, Guillermo, Gesiotto, Quinto J, Gavralidis, Alexander, Hunter, Anthony M, Lee, Jung-Hoon, Kuykendall, Andrew T, Talati, Chetasi, Sweet, Kendra L, Lancet, Jeffrey E, Padron, Eric, Hussaini, Mohammad, Song, Jinming, Garcia-Manero, Guillermo, Komrokji, Rami S, Sallman, David A
Published in Leukemia (01.04.2022)
Published in Leukemia (01.04.2022)
Get full text
Journal Article
A phase 2 trial of the oral smoothened inhibitor glasdegib in refractory myelodysplastic syndromes (MDS)
Sallman, David A., Komrokji, Rami S., Sweet, Kendra L., Mo, Qianxing, McGraw, Kathy L., Duong, Vu H., Zhang, Ling, Nardelli, Lisa Ann, Padron, Eric, List, Alan F., Lancet, Jeffrey E.
Published in Leukemia research (01.06.2019)
Published in Leukemia research (01.06.2019)
Get full text
Journal Article